| Financial Year |
March 31 2023 |
| Monetary Funds |
816,740,030.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
308,678,758.73 |
| Accounts Receivable |
1,081,345,832.73 |
| Advances to Suppliers |
151,860,335.18 |
| Other Receivables |
65,411,332.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
56,666.67 |
| Dividend Receivable |
-- |
| Inventories |
1,064,768,925.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,721,381.49 |
| Total Current Assets |
3,501,526,597.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
784,589,936.29 |
| Investment Properties |
25,899,650.10 |
| Fixed Assetes |
2,630,383,956.67 |
| Under-construction Projects |
301,415,189.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
653,269,151.93 |
| R&D expenses |
66,090,664.27 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,064,891.63 |
| Deferred Income Tax Assets |
55,718,803.23 |
| Other Non-Current Assets |
46,997,719.26 |
| Sub-Total of Non-Current Assets |
4,623,592,284.98 |
| Total Assets |
8,125,118,882.04 |
| Short-Term Loans |
323,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,170,922.61 |
| Accounts Payable |
261,088,042.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,847,107.83 |
| Taxes Payable |
66,393,022.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
411,227,129.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,616,560.00 |
| Other Current Liabilities |
2,618,528.54 |
| Sub-Total of Current Liabilities |
1,453,220,141.18 |
| Long-term Loans |
74,220,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
29,514,998.41 |
| Deferred Income Tax Liabilities |
16,747,409.08 |
| Other Non-Current Liabilities |
61,124,979.47 |
| Sub-Total of Non-Current Liabilities |
205,871,806.84 |
| Total Liabilities |
1,659,091,948.02 |
| Paid-In Capital(Or Share Stock) |
1,021,148,260.00 |
| Capital Surplus |
563,497,712.61 |
| Surplus Reserve |
399,359,221.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,441,795,760.28 |
| Minority Stockholder's Interest |
1,036,187,052.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,429,839,881.62 |
| Owner's Equity（Stockholder's Equity） |
6,466,026,934.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,125,118,882.04 |
